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RESULTS

Lower Del-1 expression in old mice
Old age is associated with greater susceptibility to inflammatory diseases 14, 16, 17 , several of which, including periodontitis, involve neutrophil-mediated tissue injury 2, 7, 8, 18 . Aging mice, like aging humans, can develop periodontitis 14, 19 . We determined whether age-related mouse periodontitis was associated with changes in Del-1 expression. Given that Del-1 is expressed in only some tissues (in brain and lungs but not liver or spleen) 3 , we first confirmed that Del-1 mRNA and protein were expressed in the gingival tissue of the periodontium ( Supplementary Fig. 1a,b) . Immunohistochemical analysis of Del-1, as well as β-galactosidase in reporter mice in which expression of β-galactosidase is controlled by the Edil3 promoter and is thus a reporter for Del-1 expression, showed that Del-1 was produced locally by endothelial cells, although it was also present in gingival extravascular areas ( Supplementary Fig. 1 ), apparently due to diffusion after its secretion by the endothelium. Similar to BALB/c mice 19 , C57BL/6 mice developed periodontal bone loss in old age (Fig. 1a, inset) . Notably, gingival tissue collected from 18-month-old mice had about 25% the Del-1 mRNA in gingiva from young mice 8-10 weeks of age (Fig. 1b) , and we also noted a considerable difference at the protein level (Fig. 1c, top) . Notably, the lower expression of Del-1 in the gingiva of old mice was associated with more neutrophil infiltration than that in young mice (Fig. 1c,d) .
We calculated bone loss in old mice by measuring the distance between the cementoenamel junction and the alveolar bone crest (Fig. 1a, inset) . Linear-regression analysis of those values versus Del-1 expression (Fig. 1a,b ) demonstrated a significant inverse association between Del-1 expression and periodontal bone loss in old mice (r 2 = 0.6254; P = 0.0065; Fig. 1e ). This association was also significant, but not as strong, in the young mice (r 2 = 0.4641; P = 0.0301; Fig. 1f ). Thus, there was an inverse relationship between Del-1 expression and bone loss not only in young mice versus old mice (Fig. 1a,b) but also within the two age groups. These data suggested that aging was associated with periodontal Del-1 deficiency, which may contribute to dysregulated or enhanced neutrophil recruitment and bone loss.
Enhanced inflammation and bone loss in Del-1-deficient mice To identify the direct role of Del-1 in local inflammatory pathology, we investigated the periodontal phenotype of Del-1-deficient (Edil3 −/− ) mice. At 16 weeks of age, Edil3 −/− mice of either sex had significantly greater periodontal bone loss than did their respective age-matched wild-type littermates (Fig. 2a) . Analysis of the periodontal inflammatory response by real-time quantitative PCR showed significant differences between Edil3 −/− mice and wild-type control mice, characterized by higher expression of IL-17 (IL-17A) in mice with Del-1 deficiency, sixfold or more than that in wild-type mice (Fig. 2b, left) . We observed significant but less pronounced upregulation in the transcript abundance of other inflammatory molecules, such as bone-resorptive mediators (TNF, IL-6 and RANKL), chemokines (CCL2 and CCL20), chemokine receptors (CCR2 and CCR6), receptors that amplify inflammation (C3aR, C5aR and TREM-1) and costimulatory molecules (CD40 and CD86); however, both Edil3 −/− and wild-type mice had similar expression of the RANKL inhibitor osteoprotegerin (Fig. 2b, left) . Moreover, Edil3 −/− mice had higher gingival expression of both the p40 and p19 subunits of IL-23 ( Fig. 2b,  left) , a potent inducer of IL-17 production by cells of both the adaptive and innate immune systems 20 .
The high expression of IL-17A and greater neutrophil infiltration in Del-1 deficiency prompted us to assess possible differences in the expression of additional cytokines of the IL-17 family and neutrophil-related chemokines and receptors. IL-17F and IL-17C (but not IL-17B, IL-17D or IL-17E) were upregulated in mice with Del-1 deficiency, although their expression was at least one-third that of IL-17A (Fig. 2b, right) . The expression of IL-17RA and IL-17RC (the IL-17 receptor subunits that recognize IL-17A and IL-17F 21 ) was affected only slightly (Fig. 2b, right) . Edil3 −/− mice had significantly higher expression of the chemokines CXCL1, CXCL2, CXCL3 and CXCL5 and their receptor (CXCR2) than did wild-type control mice; however, CCL3 expression was not affected, although expression of its receptor (CCR1) was modestly upregulated in Edil3 −/− mice (Fig. 2b, right) . Therefore, Del-1 deficiency resulted in upregulation of the expression of IL-17 cytokines (mainly the IL-17A isoform), neutrophil-recruiting CXC chemokines and their receptor, as well as the neutrophil-mobilizing agent G-CSF (Fig. 2b) .
We confirmed by immunohistochemistry the higher expression of IL-17A in Edil3 −/− periodontium (Fig. 2c,d) . Similarly, we confirmed by immunohistochemistry the higher expression of RANKL in Del-1 deficiency and found that it was accompanied by more osteoclastic activity in the periodontium (Supplementary Fig. 2a-d) . Notably, the diminished inflammatory bone loss in Edil3 −/− mice was associated with (e,f) Linear-regression analysis of the cementoenamel junction-alveolar bone crest distance versus Del-1 expression in old mice (e) and young mice (f), with the data from a,b. *P < 0.01 (two-tailed t-test). Data are pooled from two independent experiments with five mice per group in each, for a total of ten mice per group (a,b,e,f), or are from two independent experiments with three mice per group in one and two mice per group in the other, for a total of five mice per group (c,d; mean ± s.d. in d). (Fig. 2d,e) , consistent with lack of Del-1-mediated regulation of neutrophil trafficking.
To exclude the possibility that the observed greater bone loss in 16-week-old Edil3 −/− mice, relative to that in age-matched wild-type control mice, was due to innately different periodontal bone heights, we examined Edil3 −/− and wild-type mice at various ages. At the age of 5 weeks, we observed no difference between Edil3 −/− and wildtype mice in bone height, whereas we noted progressive differences from the age of 8 weeks onward (Fig. 2f) . Quantitative analysis of the expression of mRNA encoding inflammatory mediators in the gingiva of Edil3 −/− mice and their wild-type littermates at the age of 8 weeks or 9 months showed similar upregulation of IL-17, neutrophilrecruiting CXC chemokines and bone-resorptive molecules in mice with Del-1 deficiency (Supplementary Fig. 3 ), as noted above in 16-week-old mice (Fig. 2b) . Therefore, the bone loss of Edil3 −/− mice was an acquired trait rather than an innate trait and was inflammatory in nature. The effect of Del-1 deficiency on periodontal bone loss could not also be related to general bone defects in Edil3 −/− mice, as their total bone density in the femur and spine was similar to that of wild-type mice, with only slightly lower trabecular bone density of the femur but not of the spine due to Del-1 deficiency ( Supplementary  Fig. 2e ). As female and male Edil3 −/− mice had similar susceptibility to periodontitis (Fig. 2a) , we used exclusively female mice in further studies. To allow data comparison across figures, we calculated all subsequent bone loss relative to a common baseline, determined by the bone heights of 5-week-old mice.
Although it is mainly the host inflammatory response that can inflict damage on the periodontal tissue, oral anaerobic bacteria are involved in the initiation and progression of periodontitis 22, 23 . In this context, we found that at 5 weeks of age or less, Edil3 −/− mice and their wild-type littermates had similar numbers of bacteria (determined by anaerobic culture or by quantitative PCR analysis of 16S rRNA, which additionally allowed unculturable bacteria to be counted); however, from the age of 8 weeks onward, Edil3 −/− mice had a much greater bacterial burden than that of age-matched wild-type control mice ( Supplementary Fig. 4a,b) . The development of periodontal bone loss in Edil3 −/− mice was prevented by oral treatment with antibiotics ( Supplementary Fig. 4c) , which confirmed the involvement of bacteria in this bone-loss model, as in human periodontitis 23 . In summary, the periodontium of Edil3 −/− mice showed unregulated neutrophil infiltration, a greater bacterial burden and inflammatory bone loss, which indicated that Del-1 deficiency compromised host homeostasis.
Dependence of Edil3 −/− periodontitis on LFA-1 and IL-17R As Del-1 acts as an antagonist of LFA-1-dependent neutrophil adhesion 4 , we next addressed whether the bone loss noted in Edil3 −/− mice could be attributed to more LFA-1-mediated recruitment of inflammatory cells. For this, we examined the phenotype of 20-week-old mice with combined deficiency in Del-1 and LFA-1 (Edil3 −/− Itgal −/− mice). We found that the periodontal bone loss associated with Del-1 deficiency was considerably inhibited (>75%) in Edil3 −/− Itgal −/− mice (Fig. 3a) , which additionally had less neutrophil infiltration in the gingiva than did Edil3 −/− mice (Fig. 3b,c) . Consistent with the immunohistochemical findings (Fig. 3b) , Edil3 −/− Itgal −/− mice had a lower abundance in the gingiva of myeloperoxidase (MPO; a quantitative marker of neutrophil infiltration) and the neutrophil-specific peptidoglycan-recognition protein PGRP-1 than did Edil3 −/− mice (Fig. 3d) . Mouse Del-1 competitively inhibits LFA-1-dependent adhesion of mouse neutrophils to mouse endothelial cells 4 . Consistent with those findings, human Del-1 also inhibited the LFA-1-dependent transendothelial migration of human neutrophils (Fig. 3e) . These data collectively suggested that the protective effect of Del-1 against periodontitis was mediated through regulation of LFA-1-dependent neutrophil trafficking.
Edil3 −/− Itgal −/− mice had less gingival elaboration of IL-17 than did Edil3 −/− mice (Fig. 3c,f) due at least in part to less infiltration of npg neutrophils that expressed IL-17. In this context, we observed colocalization of IL-17 with Ly6G (a neutrophil marker) in the gingival tissues of both Edil3 −/− mice and Edil3 −/− Itgal −/− mice by immunohistochemistry ( Fig. 3f) . This observation was consistent with the idea that much of the IL-17 released at sites of inflammation is derived from cells of the innate immune response, including neutrophils 20 . Moreover, we directly demonstrated expression of IL-17 mRNA and protein in mouse neutrophils isolated from bone marrow ( Supplementary  Fig. 5a ,b), which confirmed published reports [24] [25] [26] [27] [28] [29] . Although gingival CD4 + T cells also seemed to express IL-17, as indicated by immunohistochemistry ( Supplementary Fig. 6a ), their numbers were not greater in mice with Del-1 deficiency ( Supplementary Fig. 6b-d ).
In contrast, cells expressing the γδ T cell antigen receptor, which also produce IL-17 (ref. 20) , seemed to localize together with IL-17 in the gingiva, and they were modestly but significantly more abundant in Edil3 −/− mice than in wild-type mice (P < 0.01; Supplementary  Fig. 6e,f) . Notably, γδ T cells showed a very high degree of colocalization with IL-17 (80.5%) in the gingiva of 20-week-old Edil3 −/− mice, whereas CD4 + T cells had significantly less colocalization with IL-17 (34.2% (P < 0.01); Supplementary Fig. 5c ). These findings suggested that the initial production of IL-17 that triggered the recruitment of the first waves of neutrophils may have been mainly a contribution of other cell types, such as CD4 + T cells and especially γδ T cells, which seemed to be an important innate source of IL-17 in Edil3 −/− gingival tissue. As Edil3 −/− mice had higher expression of IL-17 than did wild-type or Edil3 −/− Itgal −/− mice, we next sought to determine the precise role of IL-17 in bone loss associated with Del-1 deficiency. Predicting the role of IL-17 in disease (protective or destructive) is often uncertain, as IL-17 can mediate both antimicrobial host defenses and immunopathology 22, 30 . To conclusively address the role of IL-17, we generated mice with combined deficiency in Del-1 and IL-17R (Edil3 −/− Il17ra −/− mice). In contrast to 20-week-old Edil3 −/− mice, age-matched Edil3 −/− Il17ra −/− mice were completely protected against bone loss ( Fig. 4a and Supplementary Fig. 7) , which suggested that IL-17R signaling was required for the induction of periodontal bone loss associated with Del-1 deficiency. Similarly, Il17ra −/− mice had no distinct periodontal phenotype ( Supplementary Fig. 8a ); in fact, Il17ra −/− mice and Edil3 −/− Il17ra −/− mice at 30 weeks of age had greater bone heights than those of wild-type mice ( Supplementary  Fig. 8b ). These data confirmed that Edil3 −/− Itgal −/− mice were protected against periodontitis; in addition, mice of all four genotypes investigated had similar bone heights at the young age of 5 weeks (Fig. 4b) , which ruled out the possibility of an innate etiology for the bone-loss differences in the mutant mice at 20 weeks of age (Fig. 4a) . Collectively, these results indicated that Del-1 deficiency caused periodontal inflammation and bone loss that was dependent on LFA-1-mediated recruitment of neutrophils and signaling via IL-17R. The greater bacterial load due to Del-1 deficiency ( Supplementary  Fig. 4a,b) was abrogated in both Edil3 −/− Itgal −/− mice and Edil3 −/− Il17ra −/− mice (Fig. 4c) . Moreover, the oral microbiota of Edil3 −/− mice was qualitatively different from that of their wild-type littermates; the composition of the oral microbiota was further altered in the progeny of Edil3 −/− mice bred with Itgal −/− mice or Il17ra −/− mice (Fig. 4d) , which suggested that host genetics may determine the composition of the host-associated microbiota. The finding that mice of each genotype, whether resistant or susceptible to periodontitis, had qualitatively different oral microbiota suggested that compositional shifts away from the wild-type microbiota were not necessarily involved in disease pathogenesis. However, the observed changes to the microbiota in the presence of overt inflammation (as seen in Del-1 deficiency) were consistent with findings that certain oral biofilm species thrive under excessive inflammation, which generates tissue-breakdown products that serve their nutritional needs 31 . That idea was further supported by observation that treatment of mice with the anti-inflammatory agent meloxicam (a selective cyclooxygenase-2 inhibitor) resulted in a lower bacterial load, even though it also resulted in less neutrophil infiltration (Supplementary Fig. 9 ). Therefore, destructive inflammation may actually support the overgrowth of periodontal bacteria despite the recruitment of large numbers of neutrophils, consistent with our finding that the considerable bacterial burden associated with Del-1 deficiency was restored to near normal numbers in Edil3 −/− Itgal −/− mice and Edil3 −/− Il17ra −/− mice.
IL-17 regulates Del-1 expression
As IL-17 can orchestrate the production, recruitment and activation of neutrophils during inflammation 32,33 , we next assessed whether IL-17 additionally regulates Del-1 expression. We found that Il17ra −/− mice had higher gingival expression of Del-1 mRNA and protein than did wild-type control mice (Fig. 5a-c) . Moreover, local microinjection of monoclonal antibody (mAb) to IL-17 into the gingiva of old mice resulted in significant upregulation of Del-1 expression, whereas microinjection of an isotype-matched control antibody had no effect (Fig. 5d) . Furthermore, the gingival expression of IL-17 was greater in old age (Fig. 5e) , in contrast to the lower Del-1 expression in old mice (Fig. 1b) . Linear-regression analysis of Del-1 expression versus IL-17 expression in the same set of 18-month-old mice (Figs. 1b  and 5e ) identified a significant inverse association between IL-17 and Del-1 (r 2 = 0.6274; P = 0.0063; Fig. 5f ). Consistent with those findings, diseased (inflamed) gingival sites from human patients with periodontitis had significantly higher expression of IL-17A and correspondingly lower expression of Del-1 mRNA than did control healthy sites from the same people (P < 0.05; Supplementary Fig. 10) . Therefore, the inverse association between Del-1 expression and IL-17A expression also characterized human periodontium.
To determine the contribution of local IL-17R signaling to Del-1 regulation, we generated the following combinations of bone marrow chimeras (designated as donor bone marrow→lethally irradiated recipient): wild-type (WT)→WT, Il17ra −/− →WT, Il17ra −/− → Il17ra −/− and WT→Il17ra −/− . At 6 weeks after reconstitution of the bone marrow, Il17ra −/− recipient mice had significantly higher gingival expression of Del-1 than wild-type recipient mice had, regardless of whether they received wild-type or Il17ra −/− bone marrow (Fig. 5g,  left) . Therefore, high Del-1 expression correlated with lack of IL-17R signaling on stromal cells. Notably, Il17ra −/− →WT mice had slightly higher Del-1 expression than did WT→WT mice (Fig. 5g, left) . 
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A r t i c l e s MPO amounts were greatest in WT→WT mice and were incrementally lower in Il17ra −/− →WT and Il17ra −/− →Il17ra −/− mice, following the inverse pattern of Del-1 expression (Fig. 5g) . IL-17R signaling on hematopoietic cells contributes to the regulation of neutrophil recruitment (although not as potently as IL-17R signaling on stromal cells) 34 , possibly because IL-17 can directly stimulate the chemotactic recruitment of neutrophils 35 . Consistent with that, neutrophil recruitment, assessed by measurement of gingival MPO, was greater in WT→Il17ra −/− mice than in Il17ra −/− →Il17ra −/− mice, whereas Il17ra −/− →WT mice had less MPO than did WT→WT mice (Fig. 5g, right) . Less neutrophil infiltration could have thus caused less local IL-17 production, which would account for the higher Del-1 expression (Fig. 5g, left) .
Therefore, gingival Del-1 expression was regulated by IL-17R signaling mainly on stromal cells and was correlated with the recruitment of neutrophils to gingival tissue. The stromal cells involved were most likely endothelial cells, as gingival Del-1 expression was located specifically in endothelial cells (Supplementary Fig. 1) . Consistent with the ability of IL-17 to inhibit endothelial expression of Del-1 in mouse gingiva, human IL-17A inhibited Del-1 expression in human endothelial cells (Fig. 5h) . Although Il17ra −/− mice had less recruitment of neutrophils to the gingiva at a very young age, they had higher expression of IL-17A than did age-matched wild-type control mice (Supplementary Fig. 11 ), consistent with a published study 34 .
That early expression of IL-17 in the gingiva of Il17ra −/− mice, in the absence of substantial neutrophil infiltration, further supported the proposal that the gingival tissue contained IL-17-expressing cells, other than neutrophils, which may have formed a source of early IL-17 production for the recruitment of the first waves of neutrophils ( Supplementary Fig. 5c and Supplementary Table 1) .
Administration of Del-1 inhibits inflammatory bone loss
We next determined whether recombinant soluble Del-1 could be exploited therapeutically to reverse periodontal inflammation in old mice, which are essentially deficient in Del-1. Indeed, local microinjection of Del-1 into the gingiva resulted in less neutrophil infiltration and lower expression of IL-17 and TNF in the periodontium (Fig. 6a-c) than did similar treatment with a bovine serum albumin (BSA) control (Fig. 6d) . Notably, treatment of old mice with Del-1 suppressed both constitutive (naturally occurring) inflammation (Fig. 6a-c, top rows) and inflammation induced by exogenous oral inoculation with the human pathogen Porphyromonas gingivalis (Fig. 6a-c, bottom rows) . We confirmed by quantitative PCR the ability of Del-1 to diminish the expression of IL-17 and TNF mRNA, which additionally demonstrated a lower abundance of transcripts encoding other proinflammatory cytokines, chemokines, chemokine receptors, pattern-recognition and complement receptors, and costimulatory molecules (Supplementary Table 2) .
We next investigated whether Del-1 inhibited bone loss. Because naturally induced bone loss is a slow process and long-term delivery of Del-1 in mice until old age would not be practically feasible, we used the ligature-induced model of periodontitis. In this model, a silk ligature is placed around molar teeth, which results in massive local accumulation of bacteria and the induction of rapid bone loss in conventional rodents (but not in germ-free rodents) 36 . We confirmed that this model led to the recruitment of neutrophils to the periodontium (as shown by a much greater abundance of MPO), accompanied by the upregulation of inflammatory markers (such as IL-17A, chemokines and RANKL) and by downregulation of Del-1 ( Supplementary  Fig. 12 ). Therefore, this is an appropriate model with which to assess whether treatment with Del-1 inhibits inflammatory bone loss. We microinjected Del-1, expressed as a fusion protein with the Fc fragment of human immunoglobulin G (IgG), which may increase the bioavailability of Del-1 in the tissue, in the gingiva 1 d before placement of the ligature and every day thereafter until the day before we killed the mice on day 5. In contrast to microinjection of the control protein (Fc fragment alone), which had no significant effect, the Del-1-Fc fusion protein inhibited the induction of bone loss by ~70% in 18-month-old mice and by ~80% in 10-week-old mice relative to no treatment (Fig. 7a) . The reversal of periodontitis in Edil3 −/− Il17ra −/− mice relative to that in Edil3 −/− mice suggested that IL-17 might mediate the induction of bone loss. Indeed, local administration of mAb to IL-17A inhibited ligature-induced bone loss in both young mice and old mice (Fig. 7a) .
In contrast to its potent protective effect in normal, LFA-1-sufficient mice, treatment with Del-1-Fc had a minor but not statistically significant effect on bone loss in Itgal −/− mice (Fig. 7b) . That finding was consistent with the significant inhibition of periodontitis in Edil3 −/− Itgal −/− mice relative to that in Edil3 −/− mice. These results established that the protective effect of Del-1 required the presence of LFA-1 on the inflammatory cells.
We next compared Del-1-Fc with other treatments that can block LFA-1 interactions. Local administration of 1 µg LFA878, a potent small-molecule LFA-1 inhibitor 37 , conferred protection almost (but not completely) similar to that afforded by 1 µg Del-1-Fc; however, npg LFA878 was less protective than Del-1-Fc when the two molecules were administered in equimolar amounts (8.4 ng and 1 µg, respectively; Fig. 7c ). Local administration of mAb to LFA-1 (M17/4) 4 was modestly protective against bone loss when given at a dose tenfold higher than the dose of Del-1-Fc (Fig. 7c) , although its efficacy approached that of Del-1-Fc when both inhibitors were given systemically (Fig. 7d) . Systemic treatment with mAb to the LFA-1 ligand ICAM-1 or a fusion of ICAM-1 and the Fc fragment (ICAM-1-Fc) conferred protection against bone loss similar to that obtained with antibody to LFA-1 (anti-LFA-1) but was significantly less effective than Del-1-Fc (Fig. 7e) . In these experiments, treatments with Fc fragment alone or with isotype-matched control antibody consistently had no effect on bone loss (Fig. 7d,e) . In summary, Del-1-Fc, given locally or systemically, seemed to be more potent in inhibiting periodontal bone loss than other inhibitors that interfere with the LFA-1-ICAM-1 interaction. The dependence of the protective effect of Del-1 on LFA-1 (Fig. 7b ) was consistent with the idea that Del-1 acted by regulating neutrophil recruitment, whereas its absence (in Edil3 −/− mice) led to periodontitis (Fig. 3a) . However, these data did not formally rule out the possibility that Del-1 deficiency may also have had direct effects on neutrophils. Challenging that possibility was the observation that neutrophils isolated from wild-type or Edil3 −/− mice had a similar intrinsic ability to migrate and induce cytokines or chemokines (Supplementary Fig. 13a,b) . Moreover, Del-1 did not exert a direct effect on the induction of cytokines and chemokines by neutrophils (Supplementary Fig. 13c) . Collectively, our findings provide proof of the concept that Del-1 has therapeutic potential for the treatment of periodontal inflammation and bone loss and perhaps other neutrophil-mediated inflammatory diseases.
DISCUSSION
We have shown here that Del-1 provided a mechanism by which a tissue self-regulated a local inflammatory response to prevent immunopathology. Specifically, Del-1 was required for homeostatic inhibition of inflammatory periodontal bone loss, which involved LFA-1-dependent recruitment of neutrophils and signaling via IL-17R. Notably, Edil3 −/− mice developed periodontitis naturally in a chronic setting of dysregulated neutrophil recruitment, without any of the experimental intervention often required in animal models of periodontitis (such as infection with a human pathogen or injection of bone loss-inducing agents) 36 .
The Edil3 −/− phenotype was mirrored in old wild-type mice, in which inflammatory bone loss was correlated with lower Del-1 expression and higher IL-17 expression. In this context, gingival Del-1 expression was downregulated by IL-17R signaling, which acted on endothelial cells. IL-17 promotes granulopoiesis and induces the chemotactic recruitment, activation and survival of neutrophils 21, 32, 33 . Now we have identified a previously unknown mechanism by which IL-17 facilitates neutrophil recruitment and promotes inflammation through downregulation of the endogenous anti-inflammatory factor Del-1. This function may be beneficial in acute defense against infection, although persistent recruitment and infiltration of neutrophils into peripheral tissues may contribute to the pathogenesis of periodontitis 7, 8 and other chronic inflammatory diseases 2, 18, 38 .
The selective recruitment of neutrophils in mice with Del-1 deficiency can be attributed in large part to the higher expression of IL-17, which recruits mainly neutrophils 39 . Moreover, the restricted expression pattern of Del-1 probably confers its tissue-specific antiinflammatory activity 3 . That role of Del-1 is in line with the finding that the growth-differentiation factor GDF-15, locally produced in the heart, protects the infarcted myocardium from excessive neutrophil infiltration by inhibiting integrin activation 40 . That study and our findings here support an emerging proposal that tissues have evolved distinct local homeostatic mechanisms to control the recruitment of inflammatory cells and prevent tissue damage.
To our knowledge, our findings also represent the first causal link between IL-17 and periodontal bone loss, consistent with the higher expression of IL-17 in human periodontitis 22, 41 . IL-17R signaling also stimulates antimicrobial immunity 42 and is associated with protection in a model of periodontitis induced by implantation of a human pathogen 43 . In a pathological context, however, IL-17 can mediate the destruction of connective tissue and bone resorption via the induction of matrix metalloproteases and RANKL 30 . Consistent with that, the higher expression of IL-17 in Del-1-deficient mice was accompanied by more periodontal production of RANKL and osteoclastic activity. 
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The demonstration that neutrophils express RANKL emphasizes their potential to directly engage in inflammatory bone destruction 44 . In line with that, much of the IL-17 in inflammatory sites is actually contributed by neutrophils [24] [25] [26] [27] [28] [29] and other cells of the innate immune response, such as γδ T cells, although IL-17 is a signature cytokine of the subset of CD4 + IL-17-producing helper T cells 20 . Although we observed colocalization of IL-17 with both neutrophils and CD4 + T cells in Edil3 −/− gingiva, CD4 + T cells were not as abundant as neutrophils. Innate γδ T cells 20 also localized together with IL-17 and were significantly but slightly more abundant in Edil3 −/− gingival than in wild-type gingiva. Notably, γδ T cells showed much more colocalization with IL-17 than did CD4 + T cells or neutrophils, although the latter approached the degree of colocalization of γδ T cell with IL-17 several weeks after the onset of the disease (at 20 weeks, when bone loss becomes pronounced). In contrast, in the early stages (8 weeks) of Del-1 deficiency-associated periodontitis, there was relatively little infiltration of neutrophils that only modestly colocalized with IL-17. These findings suggested that the initial source of IL-17 for the recruitment of the first waves of neutrophils may have been mainly other cell types, such as CD4 + T cells or, more likely, γδ T cells, consistent with their proposed function as the first line of defense and immunoregulatory cells in the human gingiva 45 . Therefore, whereas neutrophils may represent the main effector cells that contribute to inflammatory bone loss, other gingival cells, particularly γδ T cells, may provide the initial trigger by a mechanism dependent on IL-17. By virtue of their considerable abundance and ability to express IL-17 at later stages of the disease, neutrophils may eventually become an important source of IL-17 that contributes to the perpetuation of neutrophil recruitment and the inflammatory periodontal bone destruction.
The term 'inflamm-aging' was coined to describe the heightened chronic inflammatory state often associated with old age in humans 16 . In this context, the elderly have inappropriately greater periodontal inflammatory responses than do young people after similar new formation of periodontal biofilm 14 . From a mechanistic viewpoint, little is known about the effect of aging on innate immunity and inflammatory diseases 14, 17 . However, the lower expression of Del-1 could be a major mechanism that links advanced age to destructive periodontal inflammation.
Most adults experience some form of periodontal disease, and an estimated 10-15% develop severe periodontitis, which is a risk factor for systemic conditions [9] [10] [11] [12] [13] . Conventional periodontal treatment is often not sufficient to control destructive inflammation, and many patients develop recurrent disease 46 . Our findings support the feasibility of controlling the influx of neutrophils and ensuing IL-17-dependent inflammation through treatment with Del-1. As an endogenous anti-inflammatory factor, Del-1 may be a safe and promising approach for the treatment of periodontitis that could diminish the risk for associated systemic diseases and, moreover, may find application in other inflammatory and autoimmune diseases.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
